Company: BNBX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001104659-25-113220
Chunk: 0

Company: BNB PLUS CORP.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No. )</div>

Filed by the registrant x

Filed by a party other than the registrant o

Check the appropriate box:

Preliminary Proxy Statement o

Confidential for Use of the Commission only (as
permitted by Rule 14a-6(e)(2) o

Definitive Proxy Statement o

Definitive Additional Materials x

Soliciting Material Pursuant to §§ 240.14a-12
o

| BNB Plus Corp.                                                          |
| (Name of Registrant as Specified in Its Charter)                        |
| N/A                                                                     |
| (Name of Person(s) Filing Proxy Statement if other than the Registrant) |

Payment of Filing Fee (Check the appropriate box):

| x | No fee required                                                                                     |
| o | Fee paid previously with preliminary materials                                                      |
| o | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |

<div align='center'>BNB PLUS CORP.

SUPPLEMENT TO THE DEFINITIVE PROXY STATEMENT
FOR THE SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON DECEMBER 12, 2025

November 17, 2025</div>

This proxy statement supplement
(this “Supplement”) supplements the definitive proxy statement on Schedule 14A (the “Proxy Statement”) of BNB
Plus Corp. (formerly known as Applied DNA Sciences, Inc.) (the “Company”), filed by the Company with the Securities and Exchange
Commission on November 10, 2025 in connection with the Company’s Special Meeting of Stockholders scheduled to be held on December
12, 2025. This Supplement contains additional information relating to the change in the Company’s name since the filing of the Proxy
Statement. Except as specifically supplemented by the information contained in this Supplement, all information set forth in the Proxy
Statement continues to apply and should be considered in voting your shares.

THE PROXY STATEMENT CONTAINS IMPORTANT INFORMATION AND THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT

<div align='center'>NAME CHANGE</div>

Effective November 13, 202